Vimarsana
Biggest News Aggregation in the World

Lon Sens News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lon Sens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lon Sens Today - Breaking & Trending Today

Sensyne Health (LON:SENS) Stock Price Down 33.3% - Vimarsana News

Sensyne Health (LON:SENS) Stock Price Down 33.3%

Sensyne Health PLC (LON:SENS – Get Free Report)’s stock price fell 33.3% during trading on Friday . The company traded as low as GBX 0.16 ($0.00) and last traded at GBX 0.35 ($0.00). 4,449,142 shares were traded during trading, an increase of 29% from the average session volume of 3,449,819 shares. The stock had previously […]

Sensyne Health (LON:SENS) Trading Down 33.3% - Vimarsana News

Sensyne Health (LON:SENS) Trading Down 33.3%

Sensyne Health PLC (LON:SENS – Get Free Report)’s share price dropped 33.3% during trading on Friday . The company traded as low as GBX 0.16 ($0.00) and last traded at GBX 0.35 ($0.00). Approximately 4,449,142 shares were traded during mid-day trading, an increase of 29% from the average daily volume of 3,449,819 shares. The stock […]

Sensyne Health (LON:SENS) Stock Price Down 33.3% - Vimarsana News

Sensyne Health (LON:SENS) Stock Price Down 33.3%

Sensyne Health PLC (LON:SENS – Get Rating) shares were down 33.3% on Thursday . The company traded as low as GBX 0.16 ($0.00) and last traded at GBX 0.35 ($0.00). Approximately 4,449,142 shares changed hands during mid-day trading, an increase of 29% from the average daily volume of 3,449,819 shares. The stock had previously closed […]

Sensyne Health (LON:SENS) Stock Price Down 33.3% - Vimarsana News

Sensyne Health (LON:SENS) Stock Price Down 33.3%

Sensyne Health PLC (LON:SENS – Get Rating) shares dropped 33.3% during mid-day trading on Tuesday . The stock traded as low as GBX 0.16 ($0.00) and last traded at GBX 0.35 ($0.00). Approximately 4,449,142 shares changed hands during mid-day trading, an increase of 29% from the average daily volume of 3,449,819 shares. The stock had […]

Source: wkrb13.com
Sensyne signs government deal for covid tests study | 12 March 2021 - Vimarsana News

Sensyne signs government deal for covid tests study | 12 March 2021

12 March 2021 | 09:39am StockMarketWire.com - Clinical AI technology company Sensyne has signed a £470,000 agreement with the Department of Health & Social Care (DHSC) to conduct the second stage of a pilot study of its MagnifEye technology for use with COVID-19 lateral flow diagnostic tests. The MagnifEye system is a software application available as both a smartphone app and a web application, that uses a cloud-based deep learning algorithm to automate the reading and analysis of different diagnostic tests, including lateral flow tests. The agreement with the DHSC follows an announcement...